Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNH1 intronic transcript 1 (KCNH1-IT1) is a long non-coding RNA (lncRNA) gene situated within the KCNH1 locus. It does not encode a protein and is classified as lncRNA. Its biological functions are not well-described in current gene and molecular databases, and there are no reported associations with disease or therapeutics as of the latest available sources[3]. KCNH1-IT1 is distinct from the protein-coding gene KCNH1, which encodes the potassium voltage-gated channel subfamily H member 1 (Kv10.1/EAG1), a bona fide ion channel implicated in neuronal excitability and certain diseases[1][2]. KCNH1-IT1 is classified by major molecular databases as lncRNA, with no documented molecular function or therapeutic targeting relevance[3]. No clinically actionable disease roles, drug interactions, or biomarker applications are reported in major genetic resources for KCNH1-IT1[3]. If further data emerges on transcriptional regulation or new disease links for KCNH1-IT1, those may warrant updating the above entries. Current known information, however, supports that KCNH1-IT1 is an RNA without established function or role as a therapeutic target[3].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KCNH1 intronic transcript 1 (KCNH1-IT1).